Perceptive Advisors LLC Y M Abs Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $1.74 Million - $3.21 Million	212,018 New	212,018 $3.21 Million
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $12.5 Million - $15.5 Million	-355,366 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$23.66 - $49.53 $3.95 Million - $8.28 Million	-167,114 Reduced 31.98%	355,366 $15.4 Million
Q1 2020 May 15, 2020	SELL	$14.39 - $35.8 $572,103 - $1.42 Million	-39,757 Reduced 7.07%	522,480 $12.1 Million
Q4 2019 Feb 14, 2020	SELL	$23.81 - $33.78 $6.97 Million - $9.89 Million	-292,703 Reduced 34.24%	562,237 $17.6 Million
Q3 2019 Nov 14, 2019	BUY	$21.57 - $31.37 $18.4 Million - $26.8 Million	854,940 New	854,940 $22.3 Million

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.